FI874414A - Kontrollerat frigoerande farmaceutiska kompositioner. - Google Patents

Kontrollerat frigoerande farmaceutiska kompositioner. Download PDF

Info

Publication number
FI874414A
FI874414A FI874414A FI874414A FI874414A FI 874414 A FI874414 A FI 874414A FI 874414 A FI874414 A FI 874414A FI 874414 A FI874414 A FI 874414A FI 874414 A FI874414 A FI 874414A
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
controlled pharmaceutical
controlled
composition
pharmaceutical
Prior art date
Application number
FI874414A
Other languages
English (en)
Finnish (fi)
Other versions
FI874414A0 (fi
Inventor
Henry C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI874414A0 publication Critical patent/FI874414A0/fi
Publication of FI874414A publication Critical patent/FI874414A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
FI874414A 1986-10-09 1987-10-07 Kontrollerat frigoerande farmaceutiska kompositioner. FI874414A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI874414A0 FI874414A0 (fi) 1987-10-07
FI874414A true FI874414A (fi) 1988-04-10

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874414A FI874414A (fi) 1986-10-09 1987-10-07 Kontrollerat frigoerande farmaceutiska kompositioner.

Country Status (24)

Country Link
JP (1) JPS63101334A (de)
KR (1) KR880004801A (de)
AU (1) AU7942087A (de)
BE (1) BE1000732A5 (de)
CA (1) CA1332809C (de)
CH (1) CH675831A5 (de)
DE (1) DE3733540A1 (de)
DK (1) DK527487A (de)
ES (1) ES2014518A6 (de)
FI (1) FI874414A (de)
FR (1) FR2604902B1 (de)
GB (2) GB8624213D0 (de)
GR (1) GR871550B (de)
HU (1) HU201875B (de)
IL (1) IL84104A0 (de)
IT (1) IT1221493B (de)
LU (1) LU87009A1 (de)
NL (1) NL8702294A (de)
NO (1) NO874200L (de)
NZ (1) NZ222083A (de)
PH (1) PH24227A (de)
PT (1) PT85880B (de)
SE (1) SE8703889L (de)
ZA (1) ZA877617B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
NZ514890A (en) 1999-03-31 2003-05-30 Janssen Pharmaceutica Nv Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
ES2330227T3 (es) * 2004-09-09 2009-12-07 Psicofarma, S.A. De C.V. Composicion farmaceutica de liberacion prolongada de hidralazina y su uso como apoyo para el tratamiento de cancer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
CA1332809C (en) 1994-11-01
GB8624213D0 (en) 1986-11-12
BE1000732A5 (fr) 1989-03-21
AU7942087A (en) 1988-04-14
PT85880B (pt) 1990-07-31
DK527487A (da) 1988-04-10
NO874200D0 (no) 1987-10-07
GB8723515D0 (en) 1987-11-11
HUT52958A (en) 1990-09-28
PH24227A (en) 1990-05-04
SE8703889D0 (sv) 1987-10-08
GR871550B (en) 1988-02-15
NO874200L (no) 1988-04-11
PT85880A (en) 1987-11-01
NL8702294A (nl) 1988-05-02
IT8748469A0 (it) 1987-10-08
FI874414A0 (fi) 1987-10-07
HU201875B (en) 1991-01-28
SE8703889L (sv) 1988-04-10
GB2195893B (en) 1991-05-08
FR2604902B1 (fr) 1991-04-26
JPS63101334A (ja) 1988-05-06
ZA877617B (en) 1989-05-30
FR2604902A1 (fr) 1988-04-15
LU87009A1 (fr) 1988-05-03
DE3733540A1 (de) 1988-04-14
IT1221493B (it) 1990-07-06
ES2014518A6 (es) 1990-07-16
CH675831A5 (de) 1990-11-15
KR880004801A (ko) 1988-06-27
GB2195893A (en) 1988-04-20
NZ222083A (en) 1991-05-28
DK527487D0 (da) 1987-10-08
IL84104A0 (en) 1988-03-31

Similar Documents

Publication Publication Date Title
DE3761146D1 (de) Detergens-zusammensetzung.
DE3773631D1 (de) Polyaethylen-zusammensetzung.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
DE3870011D1 (de) Hartbutter-zusammensetzung.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DE3779948D1 (de) Sauerstoff entziehende zusammensetzung.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI893643A (fi) Farmaceutiska kompositioner.
FI872733A (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
DE3779951D1 (de) Klebrigmachende zusammensetzung.
FI883673A (fi) Farmaceutiska kompositioner.
IT1213453B (it) Composizione farmaceutica.
DE3869471D1 (de) Fiebersteigende zusammensetzung.
FI874483A0 (fi) Herbicid komposition.
DE3874071D1 (de) Zahnsteinverhindernde zusammensetzung.
FI874414A0 (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DE3773805D1 (de) Zusammensetzung.
DE3773298D1 (de) Anaesthesierende zusammensetzung.
DE3875535T2 (de) Buten-1-copolymer-zusammensetzung.
FI875616A (fi) Farmaceutiska blandningar.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG